Clinical 18F-FDG and amyloid brain positron emission tomography/CT in the investigation of cognitive impairment: where are we now?
Br J Radiol
; 92(1101): 20181027, 2019 Sep.
Article
in En
| MEDLINE
| ID: mdl-30982329
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Radiopharmaceuticals
/
Fluorodeoxyglucose F18
/
Amyloidogenic Proteins
/
Cognitive Dysfunction
/
Positron Emission Tomography Computed Tomography
Limits:
Humans
Language:
En
Journal:
Br J Radiol
Year:
2019
Type:
Article